Research News and Research

RSS

Research: Stem cell culture on soft substrate maintain homogeneous pluripotent colonies

In a paper published in the journal PLoS One, the researchers demonstrated that culturing mouse embryonic stem cells on a soft gel rather than on a hard plate or dish keeps them in their pluripotent state, a ground state with the ability to become any type of tissue.

16 Dec 2010

Tort reform legislation has not reduced physician concerns about malpractice lawsuits: Study

Physicians' fears of being sued for malpractice are out of proportion to their actual risk of being sued, according to a recent study by a University of Iowa researcher and colleagues.

16 Dec 2010

CRS report details regs issued since passage of health overhaul

The Congressional Research Service issued a new report examining the processes followed in the development of the new rules put in place since the passage of the health overhaul. Meanwhile, the omnibus spending bill now moving through Congress includes funds for Medicare and Medicaid fraud prevention.

16 Dec 2010

Novel adenovirus-based gene therapy for renal cell carcinoma

Researchers at Virginia Commonwealth University Massey Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have developed a novel virus-based gene therapy for renal cell carcinoma that has been shown to kill cancer cells not only at the primary tumor site but also in distant tumors not directly infected by the virus. Renal cell carcinoma is the most common form of kidney cancer in adults and currently there is no effective treatment for the disease once it has spread outside of the kidney.

16 Dec 2010

Sun-Times: Medicare wants pharmacists out of Plan D decision-making process

Walgreens pharmacists are no longer giving customers advice on which Medicare Part D plans best work with the customers' prescriptions by the Dec. 31 deadline, and a Medicare spokesman says that's a good thing.

16 Dec 2010

Enzon in collaboration with NCI initiates EZN-2968, EZN-2208 Phase I studies for arresting tumor growth

Enzon Pharmaceuticals, today announced the initiation of Phase I clinical studies, in collaboration with the National Cancer Institute, for two of the Company's novel oncology product candidates, EZN-2968 and EZN-2208 (PEG-SN38).

16 Dec 2010

Personalities, politics emerge from decision's aftermath

Personalities and politics swirl around news about Monday's ruling in the Virginia health law challenge, with news outlets detailing how judges in different cases reached their conclusions and examining Judge Henry Hudson's ties to a GOP consulting firm. More reports also surround the related political dust-ups and posturing.

16 Dec 2010

Synthetic derivative of curry spice can be effective neuroprotective for stroke and TBI

A synthetic derivative of the curry spice turmeric, made by scientists at the Salk Institute for Biological Studies, dramatically improves the behavioral and molecular deficits seen in animal models of ischemic stroke and traumatic brain injury.

16 Dec 2010

BPA exposure reduces quality of womens' eggs retrieved for IVF

A small-scale University of California, San Francisco-led study has identified the first evidence in humans that exposure to bisphenol A (BPA) may compromise the quality of a woman's eggs retrieved for in vitro fertilization (IVF). As blood levels of BPA in the women studied doubled, the percentage of eggs that fertilized normally declined by 50 percent, according to the research team.

16 Dec 2010

The Baltimore Sun: Stent sellers were allowed inside lab despite hospital ban

News outlets examine how the marketing of medical devices and treatments impacts health care costs and physicians' decisions.

16 Dec 2010

Researchers discover newborn's brain respond strongly to mother's voice

A mother's voice will preferentially activate the parts of the brain responsible for language learning, say researchers from the University of Montreal and the Sainte-Justine University Hospital Research Centre.

16 Dec 2010

Ocera completes two studies of OCR-002 in patients with hyperammonemia, hepatic encephalopathy

Ocera Therapeutics, Inc. announced today that it has completed two studies evaluating the safety and pharmacokinetics of OCR-002 (ornithine phenylacetate) which includes healthy volunteers and patients with liver cirrhosis. OCR-002 recently received Orphan Drug status and Fast Track designation by the United States Food and Drug Administration for the treatment of hyperammonemia (excessive ammonia levels) and resultant Hepatic encephalopathy.

16 Dec 2010

Ultrasound-based diagnosis for rapid detection of benign and malignant ovarian cancer

It is crucial to differentiate between benign and malignant ovarian cysts and tumours in a fast and reliable manner. This improves the surgical management and prognosis of the patient.

16 Dec 2010

Today's Opinions: Reviewing judge's ruling on health law's individual mandate

The legal case against it almost certainly will make its way to the Supreme Court before the individual mandate is due to take effect in 2014. But considered in its proper context, it doesn't violate the Constitution (12/15).

15 Dec 2010

Experts study obesity in young population with physical, cognitive disabilities

While the nation's obesity epidemic is the target of many programs to combat it, few such programs embrace an often-overlooked subgroup adolescents and young adults with physical or cognitive disabilities.

15 Dec 2010

MCSA Tool for colonoscopy trainees to assess cognitive and motor skills

Researchers at the Mayo Clinic in Rochester, have developed a new skills assessment tool for colonoscopy trainees.

15 Dec 2010

CADCA applauds Senators for introducing STOP Act

Community Anti-Drug Coalitions of America (CADCA) applauds Senators Chris Dodd (D-CT), Frank Lautenberg (D-NJ), Bob Casey (D-PA), and Jeff Merkley (D-OR), for today introducing the Sober Truth on Preventing (STOP) Underage Drinking Act Reauthorization, legislation designed to prevent underage drinking.

15 Dec 2010

AmoyDx receives SFDA approval for its EGFR and BRAF mutations detection kits

Amoy Diagnostics announced today that its EGFR and BRAF mutation detection kits received market approval from China's State Food and Drug Administration (SFDA). The SFDA is the competent authority for regulating drugs and in vitro diagnostics in mainland China. The approval allows AmoyDx to market the EGFR and BRAF tests for clinical use in China.

15 Dec 2010

Clinical Investigation – ground-breaking new launch from Future Science

In recognition of the methodology, progress and outcome of clinical trials, Future Science has announced the launch of the definitive title Clinical Investigation. The journal is the latest addition to the Future Science’s collection of titles addressing those areas that most impact our daily lives (available at www.future-science.com). Future Science is part of London-based Future Science Group.

15 Dec 2010

New nanotechnology based technique to detect pneumonia within minutes

University of Georgia researchers have developed a technique that can diagnose a common type of pneumonia within minutes, potentially replacing existing tests that can take several days for results.

15 Dec 2010